Ana
Chopitea Ortega
Consultora Médica
Publications dans lesquelles il/elle collabore avec Ana Chopitea Ortega (25)
2024
2023
-
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
Cancers, Vol. 15, Núm. 3
-
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma
Pancreatology, Vol. 23, Núm. 4, pp. 411-419
2021
-
Feasibility and patency of echoendoscopic anastomoses with lumen apposing metal stents depending on the gastrointestinal segment involved
Scientific Reports, Vol. 11, Núm. 1
2019
2018
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center
Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789
-
Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience
Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 658-665
2017
-
Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery
Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 379-385
2016
-
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer
British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663
2015
-
Long-term oncologic results in cancer of the rectum treated by preoperative chemoradiotherapy and surgery: An analysis of 500 cases
Revista Espanola de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 340-346
2014
-
Analysis of surgical complications of primary tumor resection after neoadjuvant treatment in stage IV colon cancer
Journal of Gastrointestinal Oncology, Vol. 5, Núm. 2, pp. 148-153
2013
-
Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer
Colorectal Disease, Vol. 15, Núm. 5, pp. 552-557
-
Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy
Diseases of the Colon and Rectum, Vol. 56, Núm. 4, pp. 416-421
-
Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology, Vol. 57, Núm. 3, pp. 1078-1087
2012
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
2011
-
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy
European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847
-
Patterns of response after preoperative treatment in gastric cancer
International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704
2010
-
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535